MannKind Corp. (MNKD)
4.035
+0.06
(+1.38%)
USD |
NASDAQ |
Sep 02, 16:00
4.035
0.00 (0.00%)
After-Hours: 16:00
MannKind Cash from Investing (Quarterly) : 17.91M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.91M |
| March 31, 2026 | 18.72M |
| December 31, 2025 | -291.96M |
| September 30, 2025 | -25.06M |
| June 30, 2025 | 6.256M |
| March 31, 2025 | 5.962M |
| December 31, 2024 | 48.22M |
| September 30, 2024 | -41.26M |
| June 30, 2024 | -55.18M |
| March 31, 2024 | -48.44M |
| December 31, 2023 | -7.895M |
| September 30, 2023 | -11.55M |
| June 30, 2023 | 3.664M |
| March 31, 2023 | 13.79M |
| December 31, 2022 | 15.01M |
| September 30, 2022 | 27.35M |
| June 30, 2022 | 2.022M |
| March 31, 2022 | -39.51M |
| December 31, 2021 | -12.58M |
| September 30, 2021 | 4.992M |
| June 30, 2021 | -112.53M |
| March 31, 2021 | -31.42M |
| December 31, 2020 | -4.48M |
| September 30, 2020 | -0.004M |
| June 30, 2020 | -0.15M |
| Date | Value |
|---|---|
| March 31, 2020 | 19.85M |
| December 31, 2019 | -0.202M |
| September 30, 2019 | 3.761M |
| June 30, 2019 | -1.369M |
| March 31, 2019 | -25.03M |
| December 31, 2018 | -0.244M |
| September 30, 2018 | 0.01M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.024M |
| March 31, 2017 | 16.65M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -1.127M |
| December 31, 2015 | -0.312M |
| September 30, 2015 | -1.154M |
| June 30, 2015 | -4.534M |
| March 31, 2015 | -4.203M |
| December 31, 2014 | -14.21M |
| September 30, 2014 | -0.217M |
| June 30, 2014 | -8.258M |
| March 31, 2014 | -1.409M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| United Therapeutics Corp. | 87.50M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Gilead Sciences, Inc. | -10.35B |
| Vertex Pharmaceuticals, Inc. | -45.80M |
| Ocugen, Inc. | -0.021M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.63M |
| Cash from Financing (Quarterly) | 0.819M |
| Free Cash Flow | -18.30M |
| Free Cash Flow Per Share (Quarterly) | -0.0767 |
| Free Cash Flow to Equity (Quarterly) | -23.39M |
| Free Cash Flow to Firm (Quarterly) | -8.977M |
| Free Cash Flow Yield | -1.47% |